ÂÜÀòÂÒÂ×

Robert Lalley, PharmD, currently serves as a Senior Medical Science Liaison at Kura Oncology, Inc. since March 2023, following a role as Senior Health Systems Medical Affairs Director at Epizyme from May 2021 to December 2022. Previously, Robert worked at Apobiologix from January 2016 to May 2021, where responsibilities included prelaunch activities and successful support of two G-CSF biosimilars. Robert's experience also includes positions as a Medical Science Liaison at The Medical Affairs Company (TMAC) and as a Clinical Trial Liaison at PRA Health Sciences, where relationship building with clinical trial investigators was essential. Additionally, Robert held roles in oversight group management at Novella Clinical and served as a pharmacist at CVS Caremark Corporation. Robert completed a Doctor of Pharmacy and a Master of Science in Clinical Research from Campbell University, and holds a Bachelor of Science in Biology from Virginia Tech.